A test case has demonstrated that the European Court of Human Rights (ECHR) does not consider access to cannabis to be a universal human right and that balancing a cannabis user’s human rights with public interest is best left to sovereign states.

In effect the decision is a null result – leaving future similar suits to be determined on a case-by-case basis – as opposed to the ECHR finding in favour of the medical cannabis applicant, which may have created some precedent.

Read full article
I'm already a subscriber
Author default picture

CannIntelligence

This article was written by one of CannIntelligence’s international correspondents. We currently employ more than 40 reporters around the world to cover individual cannabis and cannabinoid markets. For a full list, please see our Who We Are page.

Our Key Benefits

The global cannabis market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

CannIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization